Diabetes Clinical Trials in Georgia

Showing 221-240 of 611 trials

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

NCT03724981

In this study participants will try out two different types of drug injection pens (dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study drug will be administered.

Diabetes Mellitus, Type 2

Eli Lilly and Company312 participantsStarted Oct 2018

Fresno, California, United States • Long Beach, California, United States • Palm Harbor, Florida, United States +11 more locations

COMPLETEDPhase 265 miles

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

NCT02580877

The study is a 2 arm, multi-center, randomized, open-labeled clinical trial designed to assess the effects of varying doses and schedules of oral insulin on immunological and metabolic markers in relatives at risk for type 1 diabetes (T1D).

Type 1 Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)92 participantsStarted Jan 2016

San Francisco, California, United States • Stanford, California, United States • Aurora, Colorado, United States +16 more locations

PreviousPage 12 of 31Next

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

Diabetes Trials in Other Cities

ACR | LAB Urine Analysis Test System Evaluation of Performance

Glargine U300 Hospital Trial

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Dose-ranging Study in Patients With Type 1 Diabetes Mellitus

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Rituximab in New Onset Type 1 Diabetes

Patient and Provider Assessment of Lipid Management Registry

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

Other Conditions in Georgia